Recent News

• 09.10.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.03.2025 - Lyell Immunopharma Announces the Initiation of a Phase 3 Head-to-Head CAR T-Cell Therapy Clinical Trial in Aggressive Large B-Cell Lymphoma and Formation of Expert Steering Committee
• 09.02.2025 - Lyell Immunopharma Announces Participation in September Investor Conferences
• 08.12.2025 - Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025

Recent Filings

• 08.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.19.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.15.2025 - EFFECT Notice of Effectiveness
• 08.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.13.2025 - 4 Statement of changes in beneficial ownership of securities